Cancer Immunotherapy

The Cancer Immunotherapy Program brings together basic scientists, translational investigators and clinician scientists to discover fundamental principles that regulate immune responses to cancer and to translate this understanding into novel cancer therapies. A major focus is on comprehensive immune profiling, using tools for high dimensional analysis of immune responses. Fundamental modeling of cancer therapeutics is conducted in murine models and the Program has an increasing effort in translating novel therapeutics to the clinic and utilizing patient samples to study the tumor: immune interface.

Gary Schoolnik, MD 

Professor of Medicine (Infectious Diseases), Emeritus 

Liora Schultz 

Clinical Assistant Professor of Pediatrics (Hematology and Oncology)

Brian Scott, MD 

Clinical Professor of Neurology and Neurological Sciences, and Clinical Associate Professor, by Courtesy, of Neurosurgery 


Melody Smith, MD 

Assistant Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy) 

John Sunwoo, MD 

Edward C. and Amy H. Sewall Professor in the School of Medicine and Professory, by Courtesy, of Dermatology 


Joseph Wu, MD, PhD 

Director of the Stanford Cardiovascular Institute, Simon H. Stertzer, MD, Professor and Professor of Radiology 


James Zehnder, MD 

Professor of Pathology (Research) and of Medicine (Hematology)


1 2